BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu C, Mendonça L, Yang Y, Gao Y, Shen C, Liu J, Ni T, Ju B, Liu C, Tang X, Wei J, Ma X, Zhu Y, Liu W, Xu S, Liu Y, Yuan J, Wu J, Liu Z, Zhang Z, Liu L, Wang P, Zhang P. The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET. Structure 2020;28:1218-1224.e4. [PMID: 33058760 DOI: 10.1016/j.str.2020.10.001] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Shang Z, Chan SY, Liu WJ, Li P, Huang W. Recent Insights into Emerging Coronavirus: SARS-CoV-2. ACS Infect Dis 2021;7:1369-88. [PMID: 33296169 DOI: 10.1021/acsinfecdis.0c00646] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Watanabe Y, Mendonça L, Allen ER, Howe A, Lee M, Allen JD, Chawla H, Pulido D, Donnellan F, Davies H, Ulaszewska M, Belij-Rammerstorfer S, Morris S, Krebs AS, Dejnirattisai W, Mongkolsapaya J, Supasa P, Screaton GR, Green CM, Lambe T, Zhang P, Gilbert SC, Crispin M. Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine. ACS Cent Sci 2021;7:594-602. [PMID: 34056089 DOI: 10.1021/acscentsci.1c00080] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
3 Yang JE, Larson MR, Sibert BS, Shrum S, Wright ER. CorRelator: Interactive software for real-time high precision cryo-correlative light and electron microscopy. J Struct Biol 2021;213:107709. [PMID: 33610654 DOI: 10.1016/j.jsb.2021.107709] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhang J, Cai Y, Xiao T, Lu J, Peng H, Sterling SM, Walsh RM Jr, Rits-Volloch S, Zhu H, Woosley AN, Yang W, Sliz P, Chen B. Structural impact on SARS-CoV-2 spike protein by D614G substitution. Science 2021;372:525-30. [PMID: 33727252 DOI: 10.1126/science.abf2303] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 53.0] [Reference Citation Analysis]
5 Tai L, Zhu G, Yang M, Cao L, Xing X, Yin G, Chan C, Qin C, Rao Z, Wang X, Sun F, Zhu Y. Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein. Proc Natl Acad Sci U S A 2021;118:e2112703118. [PMID: 34782481 DOI: 10.1073/pnas.2112703118] [Reference Citation Analysis]
6 Fertig TE, Chitoiu L, Terinte-Balcan G, Peteu VE, Marta D, Gherghiceanu M. The atomic portrait of SARS-CoV-2 as captured by cryo-electron microscopy. J Cell Mol Med 2021. [PMID: 34904376 DOI: 10.1111/jcmm.17103] [Reference Citation Analysis]
7 Cai Y, Zhang J, Xiao T, Lavine CL, Rawson S, Peng H, Zhu H, Anand K, Tong P, Gautam A, Lu S, Sterling SM, Walsh RM, Rits-Volloch S, Lu J, Wesemann DR, Yang W, Seaman MS, Chen B. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. bioRxiv 2021:2021. [PMID: 33880477 DOI: 10.1101/2021.04.13.439709] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 7.0] [Reference Citation Analysis]
8 Hein S, Benz NI, Eisert J, Herrlein ML, Oberle D, Dreher M, Stingl JC, Hildt C, Hildt E. Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes. Vaccines (Basel) 2021;9:1419. [PMID: 34960165 DOI: 10.3390/vaccines9121419] [Reference Citation Analysis]
9 Hardenbrook NJ, Zhang P. A structural view of the SARS-CoV-2 virus and its assembly. Curr Opin Virol 2021;52:123-34. [PMID: 34915287 DOI: 10.1016/j.coviro.2021.11.011] [Reference Citation Analysis]
10 Nishima W, Kulik M. Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism. Viruses 2021;13:1126. [PMID: 34208191 DOI: 10.3390/v13061126] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yang Y, Yang M, Peng Y, Liang Y, Wei J, Xing L, Guo L, Li X, Li J, Wang J, Li M, Xu Z, Zhang M, Wang F, Shi Y, Yuan J, Liu Y. Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection. Nat Microbiol 2022. [PMID: 35132197 DOI: 10.1038/s41564-021-01051-2] [Reference Citation Analysis]
12 Srinivasa Rao ASR, Krantz SG. Mathematical analysis and topology of SARS-CoV-2, bonding with cells and unbonding. J Math Anal Appl 2021;:125664. [PMID: 34538930 DOI: 10.1016/j.jmaa.2021.125664] [Reference Citation Analysis]
13 Koenig PA, Das H, Liu H, Kümmerer BM, Gohr FN, Jenster LM, Schiffelers LDJ, Tesfamariam YM, Uchima M, Wuerth JD, Gatterdam K, Ruetalo N, Christensen MH, Fandrey CI, Normann S, Tödtmann JMP, Pritzl S, Hanke L, Boos J, Yuan M, Zhu X, Schmid-Burgk JL, Kato H, Schindler M, Wilson IA, Geyer M, Ludwig KU, Hällberg BM, Wu NC, Schmidt FI. Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape. Science 2021;371:eabe6230. [PMID: 33436526 DOI: 10.1126/science.abe6230] [Cited by in Crossref: 81] [Cited by in F6Publishing: 60] [Article Influence: 81.0] [Reference Citation Analysis]
14 Kang H, Wang X, Guo M, Dai C, Chen R, Yang L, Wu Y, Ying T, Zhu Z, Wei D, Liu Y, Wei D. Ultrasensitive Detection of SARS-CoV-2 Antibody by Graphene Field-Effect Transistors. Nano Lett 2021;21:7897-904. [PMID: 34581586 DOI: 10.1021/acs.nanolett.1c00837] [Reference Citation Analysis]
15 Mast FD, Fridy PC, Ketaren NE, Wang J, Jacobs EY, Olivier JP, Sanyal T, Molloy KR, Schmidt F, Rutkowska M, Weisblum Y, Rich LM, Vanderwall ER, Dambrauskas N, Vigdorovich V, Keegan S, Jiler JB, Stein ME, Olinares PDB, Herlands L, Hatziioannou T, Sather DN, Debley JS, Fenyö D, Sali A, Bieniasz PD, Aitchison JD, Chait BT, Rout MP. Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape. Elife 2021;10:e73027. [PMID: 34874007 DOI: 10.7554/eLife.73027] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zare H, Rezapour H, Mahmoodzadeh S, Fereidouni M. Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran. Int Immunopharmacol 2021;101:108351. [PMID: 34801416 DOI: 10.1016/j.intimp.2021.108351] [Reference Citation Analysis]
17 Jackson CB, Zhang L, Farzan M, Choe H. Functional importance of the D614G mutation in the SARS-CoV-2 spike protein. Biochem Biophys Res Commun 2021;538:108-15. [PMID: 33220921 DOI: 10.1016/j.bbrc.2020.11.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 10.5] [Reference Citation Analysis]
18 Zhang J, Chen B. Fighting SARS-CoV-2 with structural biology methods. Nat Methods 2022. [PMID: 35396469 DOI: 10.1038/s41592-022-01448-9] [Reference Citation Analysis]
19 Heinz FX, Stiasny K. Profiles of current COVID-19 vaccines. Wien Klin Wochenschr 2021;133:271-83. [PMID: 33725201 DOI: 10.1007/s00508-021-01835-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
20 Guo L, Liang Y, Li H, Zheng H, Yang Z, Chen Y, Zhao X, Li J, Li B, Shi H, Sun M, Liu L. Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors. iScience 2021;24:103426. [PMID: 34786539 DOI: 10.1016/j.isci.2021.103426] [Reference Citation Analysis]
21 Liu Z, Xia M, Chai Z, Wang D. Tracing the driving forces responsible for the remarkable infectivity of 2019-nCoV: 1. Receptor binding domain in its bound and unbound states. Phys Chem Chem Phys 2020;22:28277-85. [PMID: 33295347 DOI: 10.1039/d0cp04435k] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Watanabe Y, Mendonça L, Allen ER, Howe A, Lee M, Allen JD, Chawla H, Pulido D, Donnellan F, Davies H, Ulaszewska M, Belij-Rammerstorfer S, Morris S, Krebs AS, Dejnirattisai W, Mongkolsapaya J, Supasa P, Screaton GR, Green CM, Lambe T, Zhang P, Gilbert SC, Crispin M. Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine. bioRxiv 2021:2021. [PMID: 33501433 DOI: 10.1101/2021.01.15.426463] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 10.0] [Reference Citation Analysis]
23 Abdulla ZA, Al-Bashir SM, Al-Salih NS, Aldamen AA, Abdulazeez MZ. A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development. Pathogens 2021;10:788. [PMID: 34206507 DOI: 10.3390/pathogens10070788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
24 Khoshnood S, Arshadi M, Akrami S, Koupaei M, Ghahramanpour H, Shariati A, Sadeghifard N, Heidary M. An overview on inactivated and live-attenuated SARS-CoV-2 vaccines. J Clin Lab Anal 2022;:e24418. [PMID: 35421266 DOI: 10.1002/jcla.24418] [Reference Citation Analysis]
25 Pushpawela B, Amanatidis S, Huang Y, Flagan RC. Variability of the penetration of particles through facemasks. Aerosol Science and Technology 2022;56:186-203. [DOI: 10.1080/02786826.2021.2003291] [Reference Citation Analysis]
26 Fallon L, Belfon KAA, Raguette L, Wang Y, Stepanenko D, Cuomo A, Guerra J, Budhan S, Varghese S, Corbo CP, Rizzo RC, Simmerling C. Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket. J Am Chem Soc 2021;143:11349-60. [PMID: 34270232 DOI: 10.1021/jacs.1c00556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 Engelmann I, Alidjinou EK, Ogiez J, Pagneux Q, Miloudi S, Benhalima I, Ouafi M, Sane F, Hober D, Roussel A, Cambillau C, Devos D, Boukherroub R, Szunerits S. Preanalytical Issues and Cycle Threshold Values in SARS-CoV-2 Real-Time RT-PCR Testing: Should Test Results Include These? ACS Omega 2021;6:6528-36. [PMID: 33748564 DOI: 10.1021/acsomega.1c00166] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
28 Zhang J, Xiao T, Cai Y, Chen B. Structure of SARS-CoV-2 spike protein. Curr Opin Virol 2021;50:173-82. [PMID: 34534731 DOI: 10.1016/j.coviro.2021.08.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Arista-Romero M, Pujals S, Albertazzi L. Towards a Quantitative Single Particle Characterization by Super Resolution Microscopy: From Virus Structures to Antivirals Design. Front Bioeng Biotechnol 2021;9:647874. [PMID: 33842446 DOI: 10.3389/fbioe.2021.647874] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ni T, Frosio T, Mendonça L, Sheng Y, Clare D, Himes BA, Zhang P. High-resolution in situ structure determination by cryo-electron tomography and subtomogram averaging using emClarity. Nat Protoc 2022. [PMID: 35022621 DOI: 10.1038/s41596-021-00648-5] [Reference Citation Analysis]
31 Zhao J, Zhao S, Ou J, Zhang J, Lan W, Guan W, Wu X, Yan Y, Zhao W, Wu J, Chodosh J, Zhang Q. COVID-19: Coronavirus Vaccine Development Updates. Front Immunol 2020;11:602256. [PMID: 33424848 DOI: 10.3389/fimmu.2020.602256] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
32 Chakravarty S. COVID-19: The Effect of Host Genetic Variations on Host-Virus Interactions. J Proteome Res 2021;20:139-53. [PMID: 33301685 DOI: 10.1021/acs.jproteome.0c00637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Acevedo ML, Gaete-Argel A, Alonso-Palomares L, de Oca MM, Bustamante A, Gaggero A, Paredes F, Cortes CP, Pantano S, Martínez-Valdebenito C, Angulo J, Le Corre N, Ferrés M, Navarrete MA, Valiente-Echeverría F, Soto-Rifo R. Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile. Nat Microbiol 2022;7:524-9. [PMID: 35365787 DOI: 10.1038/s41564-022-01092-1] [Reference Citation Analysis]
34 Yan W, Zheng Y, Zeng X, He B, Cheng W. Structural biology of SARS-CoV-2: open the door for novel therapies. Signal Transduct Target Ther 2022;7:26. [PMID: 35087058 DOI: 10.1038/s41392-022-00884-5] [Reference Citation Analysis]
35 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
36 Nikonova AA, Faizuloev EB, Gracheva AV, Isakov IY, Zverev VV. Genetic Diversity and Evolution of the Biological Features of the Pandemic SARS-CoV-2. Acta Naturae 2021;13:77-88. [PMID: 34707899 DOI: 10.32607/actanaturae.11337] [Reference Citation Analysis]
37 Kordyukova LV, Shanko AV. COVID-19: Myths and Reality. Biochemistry (Mosc) 2021;86:800-17. [PMID: 34284707 DOI: 10.1134/S0006297921070026] [Reference Citation Analysis]
38 Basak M, Mitra S, Bandyopadhyay D. Pathways to community transmission of COVID-19 due to rapid evaporation of respiratory virulets. J Colloid Interface Sci 2022;619:229-45. [PMID: 35397458 DOI: 10.1016/j.jcis.2022.03.098] [Reference Citation Analysis]
39 Haas P, Muralidharan M, Krogan NJ, Kaake RM, Hüttenhain R. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology. J Proteome Res 2021;20:1133-52. [PMID: 33464917 DOI: 10.1021/acs.jproteome.0c00764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
40 Heinz FX, Stiasny K. Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action. NPJ Vaccines 2021;6:104. [PMID: 34400651 DOI: 10.1038/s41541-021-00369-6] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
41 Cai Y, Zhang J, Xiao T, Lavine CL, Rawson S, Peng H, Zhu H, Anand K, Tong P, Gautam A, Lu S, Sterling SM, Walsh RM Jr, Rits-Volloch S, Lu J, Wesemann DR, Yang W, Seaman MS, Chen B. Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science 2021;373:642-8. [PMID: 34168070 DOI: 10.1126/science.abi9745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
42 Gao S, Han R, Zeng X, Liu Z, Xu M, Zhang F. Macromolecules Structural Classification with a 3D Dilated Dense Network in Cryo-electron Tomography. IEEE/ACM Trans Comput Biol Bioinform 2021;PP. [PMID: 33729943 DOI: 10.1109/TCBB.2021.3065986] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol 2021. [PMID: 34611326 DOI: 10.1038/s41580-021-00418-x] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
44 Czajka TF, Vance DJ, Mantis NJ. Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time. Trends Microbiol 2021;29:195-203. [PMID: 33446406 DOI: 10.1016/j.tim.2020.12.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Vankadari N, Shepherd DC, Carter SD, Ghosal D. Three-dimensional insights into human enveloped viruses in vitro and in situ. Biochemical Society Transactions 2022. [DOI: 10.1042/bst20210433] [Reference Citation Analysis]
46 Kang MH, Park J, Kang S, Jeon S, Lee M, Shim JY, Lee J, Jeon TJ, Ahn MK, Lee SM, Kwon O, Kim BH, Meyerson JR, Lee MJ, Lim KI, Roh SH, Lee WC, Park J. Graphene Oxide-Supported Microwell Grids for Preparing Cryo-EM Samples with Controlled Ice Thickness. Adv Mater 2021;33:e2102991. [PMID: 34510585 DOI: 10.1002/adma.202102991] [Reference Citation Analysis]
47 Letarov AV, Babenko VV, Kulikov EE. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection. Biochemistry (Mosc) 2021;86:257-61. [PMID: 33838638 DOI: 10.1134/S0006297921030032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
48 Li S. Cryo-electron tomography of enveloped viruses. Trends Biochem Sci 2021:S0968-0004(21)00185-7. [PMID: 34511334 DOI: 10.1016/j.tibs.2021.08.005] [Reference Citation Analysis]
49 Volkan E. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era. Mol Biotechnol 2021. [PMID: 34145550 DOI: 10.1007/s12033-021-00353-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Al-sharadqah AA, Patriota AG. On estimating the boundaries of a uniform distribution under additive measurement errors. Journal of Statistical Computation and Simulation. [DOI: 10.1080/00949655.2021.2022149] [Reference Citation Analysis]
51 van Oosten L, Altenburg JJ, Fougeroux C, Geertsema C, van den End F, Evers WAC, Westphal AH, Lindhoud S, van den Berg W, Swarts DC, Deurhof L, Suhrbier A, Le TT, Torres Morales S, Myeni SK, Kikkert M, Sander AF, de Jongh WA, Dagil R, Nielsen MA, Salanti A, Søgaard M, Keijzer TMP, Weijers D, Eppink MHM, Wijffels RH, van Oers MM, Martens DE, Pijlman GP. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants. mBio 2021;12:e0181321. [PMID: 34634927 DOI: 10.1128/mBio.01813-21] [Reference Citation Analysis]
52 Atyabi SMH, Rommasi F, Ramezani MH, Ghane Ezabadi MF, Arani MA, Sadeghi MH, Ahmed MM, Rajabi A, Dehghan N, Sohrabi A, Seifi M, Nasiri MJ. Relationship between blood clots and COVID-19 vaccines: A literature review. Open Life Sciences 2022;17:401-15. [DOI: 10.1515/biol-2022-0035] [Reference Citation Analysis]